CMHC Faculty Members

Faculty of Tarsus Medical Group are leaders in healthcare

No data was found

Jean-Claude Tardif

Jean-Claude Tardif



Jean-Claude Tardif is the Director of the Research Centre at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. Dr Tardif graduated from the University of Montreal with his medical degree in 1987 and completed his training in cardiology and research in Montreal and Boston in 1994. Dr Tardif holds the University of Montreal endowed research chair in atherosclerosis. He is the Scientific Director of the Montreal Heart Institute Coordinating Centre (MHICC) and Chairman of the steering committees of the CIHR-funded Canadian Atherosclerosis Imaging Network (CAIN) and Medical Imaging Trials Network of Canada (MITNEC).

Dr Tardif has authored and co-authored more than 600 articles and abstracts in peer-reviewed publications including The New England Journal of Medicine, The Journal of the American Medical Association, The Lancet, Circulation, the Journal of the American College of Cardiology, the European Heart Journal, Nature Genetics, Genes and Development, the British Journal of Pharmacology, and Cardiovascular Research. In addition, he has written more than 30 book chapters (including in Braunwald'trade;s Textbook of Heart Disease) and has edited several books. He has given approximately 400 invited lectures around the world.

His research covers the molecular and genomic aspects of atherosclerosis and related diseases and also involves animal models, mechanistic and observational clinical studies as well as large international randomized clinical trials. Dr Tardif is or has been the international principal investigator or part of the study leadership of several large clinical trials in the field of atherosclerosis and other cardiovascular diseases.

Dr Tardif and his team have created the Beaulieu-Saucier Pharmacogenomics Center at the Montreal Heart Institute and he has created the Center of Excellence in Personalized Medicine (CEPMed), the latter funded by the Network of Centers of Excellence (NCE) of Canada and which is also supported by multiple pharmaceutical and biotechnological companies. He is one of the founding fathers of the Critical Markers Of Disease (CMOD) organization, which focuses on the development and better use of biomarkers (

Dr Tardif has won multiple awards during his career, including the Research Achievement Award of the Canadian Cardiovascular Society, the Genesis Award of Bio-Québec (for his outstanding contributions to life sciences) and the Armand-Frappier Award of the Government of Quebec. He was also named scientific personality of the year by La Presse newspaper. Because of his accomplishments, Dr Tardif was named Fellow of the Canadian Academy of Health Sciences (FCAHS).

Education and Training

Professional Highlights


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.